{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:27:07Z","timestamp":1787772427768,"version":"build-2784847793"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>To assess the role of transcutaneous electrical nerve stimulation (TENS), alone or in combination with anticholinergic drugs in the management of neurogenic bladder (NB) in spina bifida (SB).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and Methods:<\/jats:title>\n                    <jats:p>All the consecutive patients, visiting outpatient clinic between July 2017 and December 2018, who were toilet trained and at least 1 year post-SB surgery with clinical and\/or urodynamic evidence of NB, were included in the study. Out of 65 patients, 40 fulfilled the inclusion criteria and were randomised into: group A (ten patients, placebo TENS with anticholinergic agents), Group B (14 patients, TENS therapy with placebo medications) and Group C (16 patients, TENS therapy with anticholinergic medications). All the patients maintained a voiding diary and underwent assessment before and after the intervention. The study was approved by the Institutional Ethics Committee.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The presenting symptoms were urinary incontinence (100%), increased frequency (45%), straining during micturition (22.5%), urgency (22.5%), and hesitancy (30%). The demographic parameters were comparable in all the groups. After group specific intervention, the wet episodes\/day significantly improved in Group C (\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001). Similarly, the mean wet days\/week also improved significantly in Group C (6.5\u20134.37 days\/week,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01). Out of 40 patients, 29 had abnormal findings on ultrasonography before the start of the therapy. Following intervention, only two patients in Group C showed normalization of findings. On Urodynamic studies, detrusor pressure (Pdet max) decreased in all the groups; however, the patients in Group C, showed the maximum reduction (56.6 \u00b1 11\u201330 \u00b1 6.7 cm H\n                      <jats:sub>2<\/jats:sub>\n                      O). Similarly compliance (9.4 to 14.5 cm H\n                      <jats:sub>2<\/jats:sub>\n                      O,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.02) and bladder capacity (68%\u201388% of EBC,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.001) also improved significantly in Group C as compared to other 2 groups Overall, nine patients (Group A, B, and C = 1, 3, and five patients, respectively) showed detrusor instability, while post therapy, only one patient (Group B) had unstable bladder. Maximum decrease in postvoid residue (mean) was also observed in Group C (77\u201341 ml,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      = 0.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The application of TENS in NB secondary to SB is effective and its application led to improvement in symptoms, decrease in the wet episodes\/day, maximum detrusor pressure, instability, bladder compliance, and capacity. TENS therapy in combination with anticholinergic agents had a better outcome as compared to monotherapy with either of the two modalities.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/jiaps.jiaps_220_21","type":"journal-article","created":{"date-parts":[[2024,5,24]],"date-time":"2024-05-24T10:12:35Z","timestamp":1716545555000},"page":"570-576","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["Transcutaneous electrical nerve stimulation in management of neurogenic bladder secondary to spina bifida"],"prefix":"10.4103","volume":"27","author":[{"given":"Swapnil","family":"Pattanshetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jai Kumar","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somya","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-12-20240905","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJM199911113412006","article-title":"Neural-tube defects","volume":"341","author":"Botto","year":"1999","journal-title":"N Engl J Med"},{"key":"R2-12-20240905","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00467-008-0780-7","article-title":"Treatment of the neurogenic bladder in spina bifida","volume":"23","author":"de Jong","year":"2008","journal-title":"Pediatr Nephrol"},{"key":"R3-12-20240905","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.jpedsurg.2016.09.030","article-title":"Role of gabapentin and anticholinergics in management of neurogenic bladder after repair of spina bifida \u2013 A randomized controlled study","volume":"51","author":"Dash","year":"2016","journal-title":"J Pediatr Surg"},{"key":"R4-12-20240905","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s004310100741","article-title":"Bladder-spincter dysfunction in myelomeningocele","volume":"160","author":"Van Gool","year":"2001","journal-title":"Eur J Pediatr"},{"key":"R5-12-20240905","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.juro.2017.03.117","article-title":"Transcutaneous electrical nerve stimulation combined with oxybutynin is superior to monotherapy in children with urge incontinence: A randomized, placebo controlled study","volume":"198","author":"Borch","year":"2017","journal-title":"J Urol"},{"key":"R6-12-20240905","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/j.juro.2010.12.067","article-title":"Current state of nerve stimulation technique for lower urinary tract dysfunction in children","volume":"185","author":"De Gennaro","year":"2011","journal-title":"J Urol"},{"key":"R7-12-20240905","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ajur.2015.04.013","article-title":"Non-invasive transcutaneous electrical stimulation in the treatment of overactive bladder","volume":"2","author":"Slovak","year":"2015","journal-title":"Asian J Urol"},{"key":"R9-12-20240905","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1080\/20469047.2017.1351745","article-title":"The management of paediatric neurogenic bladder: An approach in a resource-poor setting","volume":"37","author":"Maison","year":"2017","journal-title":"Paediatr Int Child Health"},{"key":"R10-12-20240905","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jpurol.2020.08.002","article-title":"Magnetic resonance image connectivity analysis provides evidence of central nervous system mode of action for parasacral transcutaneous electro neural stimulation \u2013 A pilot study","volume":"16","author":"Netto","year":"2020","journal-title":"J Pediatr Urol"},{"key":"R11-12-20240905","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1002\/bdra.20499","article-title":"Characteristics of a spina bifida population including North American Caucasian and Hispanic individuals","volume":"82","author":"Au","year":"2008","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"R12-12-20240905","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/jmg.30.3.262-b","article-title":"Sex differences in the location of a spina bifida lesion","volume":"30","author":"Cuckle","year":"1993","journal-title":"J Med Genet"},{"key":"R13-12-20240905","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.juro.2013.02.034","article-title":"Posterior tibial nerve stimulation vs. parasacral transcutaneous neuromodulation for overactive bladder in children","volume":"190","author":"Barroso","year":"2013","journal-title":"J Urol"},{"key":"R14-12-20240905","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/2329048X19835656","article-title":"An Exploratory Electrical Stimulation Protocol in the Management of an Infant With Spina Bifida: A Case Report","volume":"6","author":"Motavalli","year":"2019","journal-title":"Child Neurol Open"}],"container-title":["Journal of Indian Association of Pediatric Surgeons"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/jiaps.jiaps_220_21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:46:16Z","timestamp":1787769976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/jiaps.jiaps_220_21"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/jiaps.jiaps_220_21","relation":{},"ISSN":["0971-9261"],"issn-type":[{"value":"0971-9261","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]}}}